Diagnostic difficulties and possibilities of NF1-like syndromes in childhood
Authors:
Open Access
- 29 July 2021
- journal article
- research article
- Published by Springer Nature in BMC Pediatrics
- Vol. 21 (1) , 1-14
Abstract
Background: Neurofibromatosis type 1 (NF1), which is caused by heterozygous inactivating pathogenic variants in the NF1, has poor phenotypic expressivity in the early years of life and there are numerous conditions, including many other tumor predisposition syndromes, that can mimic its appearance. These are collectively termed NF1-like syndromes and are also connected by their genetic background. Therefore, the NF1’s clinical diagnostic efficiency in childhood could be difficult and commonly should be completed with genetic testing. Methods: To estimate the number of syndromes/conditions that could mimic NF1, we compiled them through an extensive search of the scientific literature. To test the utility of NF1’s National Institutes of Health (NIH) clinical diagnostic criteria, which have been in use for a long time, we analyzed the data of a 40-member pediatric cohort with symptoms of the NF1-like syndromes’ overlapping phenotype and performed NF1 genetic test, and established the average age when diagnostic suspicion arises. To facilitate timely identification, we compiled strongly suggestive phenotypic features and anamnestic data. Results: In our cohort the utility of NF1’s clinical diagnostic criteria were very limited (sensitivity: 80%, specificity: 30%). Only 53% of children with clinically diagnosed NF1 had a detectable NF1 pathogenic variation, whereas 40% of patients without fulfilled clinical criteria tested positive. The average age at first genetic counseling was 9 years, and 40% of children were referred after at least one tumor had already been diagnosed. These results highlight the need to improve NF1-like syndromes’ diagnostic efficiency in childhood. We collected the most extensive spectrum of NF1-like syndromes to help the physicians in differential diagnosis. We recommend the detailed, non-invasive clinical evaluation of patients before referring them to a clinical geneticist. Conclusions: Early diagnosis of NF1-like syndromes can help to prevent severe complications by appropriate monitoring and management. We propose a potential screening, diagnostic and management strategy based on our findings and recent scientific knowledge.Keywords
This publication has 66 references indexed in Scilit:
- The RASopathiesAnnual Review of Genomics and Human Genetics, 2013
- Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromesAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2011
- Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutationEuropean Journal of Human Genetics, 2011
- Multiple, Unilateral Lisch Nodules in the Absence of Other Manifestations of Neurofibromatosis Type 1Case Reports in Ophthalmological Medicine, 2011
- NF1 exon 22 analysis of individuals with the clinical diagnosis of neurofibromatosis type 1American Journal of Medical Genetics Part A, 2010
- Germline mosaicism in neurofibromatosis type 1 due to a paternally derived multi‐exon deletionAmerican Journal of Medical Genetics Part A, 2010
- Tumor microenvironment and neurofibromatosis type I: connecting the GAPsOncogene, 2007
- Johanson-Blizzard Syndrome: Autopsy Findings with Special Emphasis on Hypopituitarism and Review of the LiteraturePediatric and Developmental Pathology, 2007
- Guidelines for the diagnosis and management of individuals with neurofibromatosis 1Journal of Medical Genetics, 2006
- Neurofibromatosis type 1 and sporadic optic gliomasArchives of Disease in Childhood, 2002